Drug Trial Radar · NCT02338310
Trial of Perioperative Endocrine Therapy - Individualising Care
Last checked: Nov 19, 2026Latest source record: Feb 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
4,486
Actual
Start
Sep 2008
Primary completion
Apr 2024
Study completion Apr 2034
Sponsor
- Lead sponsor
- Institute of Cancer Research, United KingdomAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 14, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine whether perioperative endocrine therapy with an aromatase inhibitor (AI) followed by standard adjuvant therapy improves outcome compared with standard adjuvant therapy alone in postmenopausal women with hormone receptor positive breast cancer. To determine whether the proliferation marker Ki67 as measured by immunohistochemistry (IHC) in the excised cancer around 2 weeks after starting AI therapy will predict for time to recurrence (TTR) in the individual patient more effectively than the pre-treatment Ki67 value. To determine whether molecular profiling 2 weeks after starting endocrine therapy predicts for long-term outcome in postmenopausal women with hormone receptor positive breast cancer better than at diagnosis.
Conditions
- Breast Cancer
Interventions
Aromatase InhibitorsDrug
Choice of AI is according to centre policy; any brand can be used
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to recurrenceTime frame: 5 years post-randomisation
Locations
128 sites in 1 country. Site status is shown where the registry gives one.
Tameside General Hospital
Ashton-under-Lyne, United Kingdom
Ysbyty Gwynedd
Bangor, United Kingdom
Royal United Hospital
Bath, United Kingdom
Queen Elizabeth Hospital
Birmingham, United Kingdom
Royal Bolton Hospital
Bolton, United Kingdom
Royal Bournemouth General Hospital
Bournemouth, United Kingdom
Bristol Royal Infirmary
Bristol, United Kingdom
Southmead Hospital
Bristol, United Kingdom
Addenbrooke's Hospital
Cambridge, United Kingdom
East Kent Hospitals
Canterbury, United Kingdom
University Hospital Of Wales
Cardiff, United Kingdom
Castle Hill Hospital
Cottingham, United Kingdom
University Hospital Coventry
Coventry, United Kingdom
Leighton Hospital
Crewe, United Kingdom
Darent Valley Hospital
Dartford, United Kingdom
Royal Derby Hospital
Derby, United Kingdom
Royal Devon and Exeter Hospital
Exeter, United Kingdom
Frimley Park Hospital
Frimley, United Kingdom
Western Infirmary
Glasgow, United Kingdom
Royal Surrey County Hospital
Guildford, United Kingdom
Hereford County Hospital
Hereford, United Kingdom
Huddersfield Royal Infirmary
Huddersfield, United Kingdom
Ipswich Hospital
Ipswich, United Kingdom
Leeds General Infirmary/ St James' University Hospital
Leeds, United Kingdom
University Hospitals of Leicester NHS Trust
Leicester, United Kingdom
Lincoln County Hospital
Lincoln, United Kingdom
Royal Liverpool University Hospital
Liverpool, United Kingdom
Homerton University Hospital
London, United Kingdom
Charing Cross Hospital
London, United Kingdom
Northwick Park Hospital
London, United Kingdom
St Bartholomew's Hospital
London, United Kingdom
Luton and Dunstable Hospital
Luton, United Kingdom
Macclesfield District General Hospital
Macclesfield, United Kingdom
Maidstone Hospital
Maidstone, United Kingdom
Hillingdon Hospital
Middlesex, United Kingdom
Milton Keynes General Hospital
Milton Keynes, United Kingdom
Norfolk and Norwich University Hospital
Norwich, United Kingdom
Nottingham City Hospital
Nottingham, United Kingdom
Derriford Hospital
Plymouth, United Kingdom
Dorset County Hospital
Poole, United Kingdom
Showing 40 of 128 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.